Trial Profile
Phase I clinical trial of CDI 244 as a potential therapy for hepatitis C.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Nov 2014
Price :
$35
*
At a glance
- Drugs CDI 244 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; First in man
- Sponsors Cocrystal Pharma Inc
- 19 Nov 2014 New trial record